FDMT
FDMT
NASDAQ · Biotechnology

4D Molecular Therapeutics In

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$11.60
+1.18 (+11.32%)
As of Jun 23, 10:04 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 14 82%
Hold 3 18%
Sell 0 0%
Price Target
Analyst Price Target +82.0% upside
Low Target $12.84
Average Target $21.11
High Target $26.25
Current Price $11.60
Current
$11.60
Target
$21.11
$12.84 $21.11 avg $26.25
Scenario Analysis
Bear Case
$12.84
10.7%
Low target
Base Case
$21.11
+82.0%
Avg target
Bull Case
$26.25
+126.3%
High target
Risk/Reward
11.8x
Highly favorable
Price in Context
52-Week High
$12.34
-6.0% from high
52-Week Low
$3.68
+215.2% from low
Target vs 52W High
$21.11
+71.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%